Literature DB >> 33712669

Antibody design using LSTM based deep generative model from phage display library for affinity maturation.

Koichiro Saka1, Taro Kakuzaki1, Shoichi Metsugi1, Daiki Kashiwagi2, Kenji Yoshida1, Manabu Wada1, Hiroyuki Tsunoda1, Reiji Teramoto3.   

Abstract

Molecular evolution is an important step in the development of therapeutic antibodies. However, the current method of affinity maturation is overly costly and labor-intensive because of the repetitive mutation experiments needed to adequately explore sequence space. Here, we employed a long short term memory network (LSTM)-a widely used deep generative model-based sequence generation and prioritization procedure to efficiently discover antibody sequences with higher affinity. We applied our method to the affinity maturation of antibodies against kynurenine, which is a metabolite related to the niacin synthesis pathway. Kynurenine binding sequences were enriched through phage display panning using a kynurenine-binding oriented human synthetic Fab library. We defined binding antibodies using a sequence repertoire from the NGS data to train the LSTM model. We confirmed that likelihood of generated sequences from a trained LSTM correlated well with binding affinity. The affinity of generated sequences are over 1800-fold higher than that of the parental clone. Moreover, compared to frequency based screening using the same dataset, our machine learning approach generated sequences with greater affinity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33712669      PMCID: PMC7955064          DOI: 10.1038/s41598-021-85274-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  29 in total

1.  Learning to forget: continual prediction with LSTM.

Authors:  F A Gers; J Schmidhuber; F Cummins
Journal:  Neural Comput       Date:  2000-10       Impact factor: 2.026

2.  Biomarker-Based Metabolic Labeling for Redirected and Enhanced Immune Response.

Authors:  Shanshan Li; Bingchen Yu; Jiajia Wang; Yueqin Zheng; Huajie Zhang; Margaret J Walker; Zhengnan Yuan; He Zhu; Jun Zhang; Peng George Wang; Binghe Wang
Journal:  ACS Chem Biol       Date:  2018-06-01       Impact factor: 5.100

3.  Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration.

Authors:  Patrick Koenig; Chingwei V Lee; Sarah Sanowar; Ping Wu; Jeremy Stinson; Seth F Harris; Germaine Fuh
Journal:  J Biol Chem       Date:  2015-06-18       Impact factor: 5.157

Review 4.  Production and characterization of a biotinylated single-chain variable fragment antibody for detection of parathion-methyl.

Authors:  Huimin Wang; Fengchun Zhao; Xiao Han; Zhengyou Yang
Journal:  Protein Expr Purif       Date:  2016-05-12       Impact factor: 1.650

5.  PyIgClassify: a database of antibody CDR structural classifications.

Authors:  Jared Adolf-Bryfogle; Qifang Xu; Benjamin North; Andreas Lehmann; Roland L Dunbrack
Journal:  Nucleic Acids Res       Date:  2014-11-11       Impact factor: 19.160

6.  Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies.

Authors:  Dongmei Hu; Siyi Hu; Wen Wan; Man Xu; Ruikai Du; Wei Zhao; Xiaolian Gao; Jing Liu; Haiyan Liu; Jiong Hong
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

7.  Next-generation sequencing enables the discovery of more diverse positive clones from a phage-displayed antibody library.

Authors:  Wonjun Yang; Aerin Yoon; Sanghoon Lee; Soohyun Kim; Jungwon Han; Junho Chung
Journal:  Exp Mol Med       Date:  2017-03-24       Impact factor: 8.718

8.  Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs.

Authors:  Kris Barreto; Bharathikumar V Maruthachalam; Wayne Hill; Daniel Hogan; Ashley R Sutherland; Anthony Kusalik; Humphrey Fonge; John F DeCoteau; C Ronald Geyer
Journal:  Nucleic Acids Res       Date:  2019-05-21       Impact factor: 16.971

9.  Synthesis of hapten, generation of specific polyclonal antibody and development of ELISA with high sensitivity for therapeutic monitoring of crizotinib.

Authors:  Mona M Al-Shehri; Adel S El-Azab; Manal A El-Gendy; Mohammed A Hamidaddin; Ibrahim A Darwish
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

10.  Coupling of Single Molecule, Long Read Sequencing with IMGT/HighV-QUEST Analysis Expedites Identification of SIV gp140-Specific Antibodies from scFv Phage Display Libraries.

Authors:  Seung Yub Han; Alesia Antoine; David Howard; Bryant Chang; Woo Sung Chang; Matthew Slein; Gintaras Deikus; Sofia Kossida; Patrice Duroux; Marie-Paule Lefranc; Robert P Sebra; Melissa L Smith; Ismael Ben F Fofana
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more
  9 in total

Review 1.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

2.  Predicting antibody binders and generating synthetic antibodies using deep learning.

Authors:  Yoong Wearn Lim; Adam S Adler; David S Johnson
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

3.  Current and Emerging Tools of Computational Biology To Improve the Detoxification of Mycotoxins.

Authors:  Natalie Sandlin; Darius Russell Kish; John Kim; Marco Zaccaria; Babak Momeni
Journal:  Appl Environ Microbiol       Date:  2021-12-08       Impact factor: 5.005

4.  In silico proof of principle of machine learning-based antibody design at unconstrained scale.

Authors:  Rahmad Akbar; Philippe A Robert; Cédric R Weber; Michael Widrich; Robert Frank; Milena Pavlović; Lonneke Scheffer; Maria Chernigovskaya; Igor Snapkov; Andrei Slabodkin; Brij Bhushan Mehta; Enkelejda Miho; Fridtjof Lund-Johansen; Jan Terje Andersen; Sepp Hochreiter; Ingrid Hobæk Haff; Günter Klambauer; Geir Kjetil Sandve; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

Review 5.  High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand.

Authors:  Nicola Zambrano; Guendalina Froechlich; Dejan Lazarevic; Margherita Passariello; Alfredo Nicosia; Claudia De Lorenzo; Marco J Morelli; Emanuele Sasso
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

6.  Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space.

Authors:  Emily K Makowski; Patrick C Kinnunen; Jie Huang; Lina Wu; Matthew D Smith; Tiexin Wang; Alec A Desai; Craig N Streu; Yulei Zhang; Jennifer M Zupancic; John S Schardt; Jennifer J Linderman; Peter M Tessier
Journal:  Nat Commun       Date:  2022-07-01       Impact factor: 17.694

Review 7.  Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery.

Authors:  Wiktoria Wilman; Sonia Wróbel; Weronika Bielska; Piotr Deszynski; Paweł Dudzic; Igor Jaszczyszyn; Jędrzej Kaniewski; Jakub Młokosiewicz; Anahita Rouyan; Tadeusz Satława; Sandeep Kumar; Victor Greiff; Konrad Krawczyk
Journal:  Brief Bioinform       Date:  2022-07-18       Impact factor: 13.994

8.  The use of deep learning technology in dance movement generation.

Authors:  Xin Liu; Young Chun Ko
Journal:  Front Neurorobot       Date:  2022-08-05       Impact factor: 3.493

Review 9.  Next-Generation Molecular Discovery: From Bottom-Up In Vivo and In Vitro Approaches to In Silico Top-Down Approaches for Therapeutics Neogenesis.

Authors:  Sophie E Kenny; Fiach Antaw; Warwick J Locke; Christopher B Howard; Darren Korbie; Matt Trau
Journal:  Life (Basel)       Date:  2022-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.